LSI INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LSI INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $155.07M | Sep 11, 2025 |
| FY2025 | Mar 31, 2025 | $132.48M | Sep 11, 2025 |
| FY2025 | Dec 31, 2024 | $147.73M | Sep 11, 2025 |
| FY2025 | Sep 30, 2024 | $138.10M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $129.01M | Sep 11, 2025 |
| FY2025 | Mar 31, 2024 | $108.19M | Sep 11, 2025 |
| FY2025 | Dec 31, 2023 | $109.01M | Sep 11, 2025 |
| FY2025 | Sep 30, 2023 | $123.44M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $123.64M | Sep 11, 2024 |
| FY2024 | Mar 31, 2023 | $117.47M | Sep 11, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $83.42M | Sep 8, 2017 |
| FY2017 | Mar 31, 2017 | $78.16M | Sep 8, 2017 |
| FY2017 | Dec 31, 2016 | $85.66M | Sep 8, 2017 |
| FY2017 | Sep 30, 2016 | $84.16M | Sep 8, 2017 |
| FY2017 | Jun 30, 2016 | $80.84M | Sep 8, 2017 |
| FY2017 | Mar 31, 2016 | $70.74M | Sep 8, 2017 |
| FY2017 | Dec 31, 2015 | $84.69M | Sep 8, 2017 |
| FY2017 | Sep 30, 2015 | $85.93M | Sep 8, 2017 |
| FY2017 | Jun 30, 2015 | $76.07M | Sep 8, 2017 |
| FY2017 | Mar 31, 2015 | $68.60M | Sep 8, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $40.43M | Sep 11, 2025 |
| FY2025 | Mar 31, 2025 | $32.84M | Sep 11, 2025 |
| FY2025 | Dec 31, 2024 | $34.86M | Sep 11, 2025 |
| FY2025 | Sep 30, 2024 | $33.65M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $33.83M | Sep 11, 2025 |
| FY2025 | Mar 31, 2024 | $31.21M | Sep 11, 2025 |
| FY2025 | Dec 31, 2023 | $31.54M | Sep 11, 2025 |
| FY2025 | Sep 30, 2023 | $36.59M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $35.86M | Sep 11, 2024 |
| FY2024 | Mar 31, 2023 | $32.20M | Sep 11, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.17M | Sep 11, 2025 |
| FY2025 | Mar 31, 2025 | $3.88M | Sep 11, 2025 |
| FY2025 | Dec 31, 2024 | $5.65M | Sep 11, 2025 |
| FY2025 | Sep 30, 2024 | $6.68M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $5.67M | Sep 11, 2025 |
| FY2025 | Mar 31, 2024 | $5.38M | Sep 11, 2025 |
| FY2025 | Dec 31, 2023 | $5.91M | Sep 11, 2025 |
| FY2025 | Sep 30, 2023 | $8.03M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $8.41M | Sep 11, 2024 |
| FY2024 | Mar 31, 2023 | $4.67M | Sep 11, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $35.77M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $35.52M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $37.03M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $21.20M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $8.03M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $13.08M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | ($19.89M) | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | ($21.65M) | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $3.61M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $13.96M | Sep 11, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.30M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $3.50M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $3.40M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $3.60M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $3.70M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $3.60M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $5.30M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $5.95M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $5.70M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $5.55M | Sep 11, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $105.94M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $97.62M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $99.88M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $88.00M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $70.92M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $68.78M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $72.47M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $79.75M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $77.27M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $69.72M | Sep 11, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $38.12M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $43.39M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $49.59M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | ($3.86M) | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $28.01M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $29.71M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $11.49M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $11.50M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $21.25M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $18.13M | Sep 11, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.47M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $5.39M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $3.21M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $2.12M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $2.23M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $2.74M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $2.62M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $3.41M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $6.63M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $10.21M | Sep 11, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $396.36M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $348.80M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $296.15M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $311.08M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $286.82M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $172.26M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $201.10M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $229.52M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $256.68M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $195.56M | Sep 11, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $139.25M | Sep 11, 2018 |
| FY2018 | Jun 30, 2017 | $160.08M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $155.52M | Sep 11, 2018 |
| FY2018 | Jun 30, 2015 | $142.95M | Sep 11, 2018 |
| FY2018 | Jun 30, 2014 | $138.41M | Sep 11, 2018 |
| FY2017 | Jun 30, 2013 | $141.69M | Sep 8, 2017 |
| FY2016 | Jun 30, 2012 | $149.37M | Sep 7, 2016 |
| FY2015 | Jun 30, 2011 | $151.22M | Sep 8, 2015 |
| FY2014 | Jun 30, 2010 | $144.22M | Sep 10, 2014 |
| FY2013 | Jun 30, 2009 | $130.47M | Sep 6, 2013 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $64.55M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $57.40M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $45.03M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $45.03M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $43.79M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $10.37M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $10.37M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $30.54M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $58.54M | Sep 11, 2018 |
| FY2017 | Jun 30, 2016 | $10.51M | Sep 8, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $66.20M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $47.79M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $28.55M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $8.22M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | ($1.41M) | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | ($1.92M) | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | ($5.81M) | Sep 11, 2020 |
| FY2020 | Jul 1, 2018 | $15.72M | Sep 11, 2020 |
| FY2020 | Jun 30, 2018 | $15.12M | Sep 11, 2020 |
| FY2018 | Jun 30, 2017 | $39.82M | Sep 11, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.46M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $4.11M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $1.83M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $2.46M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $2.28M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $3.52M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $966.0K | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $3.18M | Sep 6, 2019 |
| FY2019 | Jun 30, 2017 | $3.04M | Sep 6, 2019 |
| FY2018 | Jun 30, 2016 | $33.84M | Sep 11, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $48.56M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $54.23M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $35.20M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $79.60M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $68.18M | Sep 9, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 11, 2025 |
| FY2025 | Mar 31, 2025 | 0 | Sep 11, 2025 |
| FY2025 | Dec 31, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Sep 11, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 11, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Sep 11, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 11, 2025 |
| FY2025 | Mar 31, 2025 | 0 | Sep 11, 2025 |
| FY2025 | Dec 31, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Sep 11, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Sep 11, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 11, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Sep 11, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 30.05M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | 29.22M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | 28.49M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | 27.48M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | 26.52M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | 26.29M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | 25.97M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | 25.64M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | 24.43M | Sep 11, 2018 |
| FY2017 | Jun 30, 2016 | 24.98M | Sep 8, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.97M | Sep 11, 2025 |
| FY2025 | Jun 30, 2024 | $5.74M | Sep 11, 2025 |
| FY2024 | Jun 30, 2023 | $5.44M | Sep 11, 2024 |
| FY2023 | Jun 30, 2022 | $5.32M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $5.29M | Sep 9, 2022 |
| FY2021 | Jun 30, 2020 | $5.28M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $5.18M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $5.15M | Sep 6, 2019 |
| FY2018 | Jun 30, 2017 | $5.05M | Sep 11, 2018 |
| FY2018 | Jun 30, 2016 | $4.21M | Sep 11, 2018 |